Published in J Exp Med on March 01, 1993
The functional network of ion channels in T lymphocytes. Immunol Rev (2009) 3.21
Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov (2009) 3.12
K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci (2004) 3.12
Recovery from C-type inactivation is modulated by extracellular potassium. Biophys J (1996) 2.52
Characterization of T cell mutants with defects in capacitative calcium entry: genetic evidence for the physiological roles of CRAC channels. J Cell Biol (1995) 2.09
Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol (2005) 2.08
Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle (2009) 1.88
Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol (2001) 1.85
Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cardiovasc Res (2010) 1.57
Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med (2000) 1.52
The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc Natl Acad Sci U S A (2004) 1.37
Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci (2014) 1.29
Colocalization and nonrandom distribution of Kv1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes. Proc Natl Acad Sci U S A (2003) 1.25
Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function. Proc Natl Acad Sci U S A (2003) 1.17
Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels. Proc Natl Acad Sci U S A (1999) 1.13
A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes. J Exp Med (1998) 1.11
Voltage-gated and Ca(2+)-activated K+ channels in intact human T lymphocytes. Noninvasive measurements of membrane currents, membrane potential, and intracellular calcium. J Gen Physiol (1995) 1.10
The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy. Br J Pharmacol (2009) 1.08
Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med (2002) 1.07
Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques. Exp Biol Med (Maywood) (2007) 1.06
Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci U S A (1997) 1.06
Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. J Immunol (2012) 0.98
Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells. Mol Pharmacol (2012) 0.96
Characterization of apamin-sensitive Ca(2+)-activated potassium channels in human leukaemic T lymphocytes. J Physiol (1996) 0.95
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation. Br J Pharmacol (1999) 0.91
Antibody-guided photoablation of voltage-gated potassium currents. J Gen Physiol (2013) 0.89
Stress-induced corneal epithelial apoptosis mediated by K+ channel activation. Prog Retin Eye Res (2006) 0.89
Novel K(+)-channel-blocking toxins from the venom of the scorpion Centruroides limpidus limpidus Karsch. Biochem J (1994) 0.87
A potassium ion channel is involved in cytokine production by activated human macrophages. Clin Exp Immunol (2002) 0.85
Study of membrane potential in T lymphocytes subpopulations using flow cytometry. BMC Immunol (2008) 0.85
B-lymphocyte calcium influx. Immunol Rev (2009) 0.84
Electrophysiological characterization of Ts6 and Ts7, K⁺ channel toxins isolated through an improved Tityus serrulatus venom purification procedure. Toxins (Basel) (2014) 0.84
A charybdotoxin-insensitive conductance in human T lymphocytes: T cell membrane potential is set by distinct K+ channels. J Physiol (1997) 0.83
The role of PSD-95 in the rearrangement of Kv1.3 channels to the immunological synapse. Pflugers Arch (2013) 0.82
Ion channels in asthma. J Biol Chem (2011) 0.82
Serum-induced changes in the physiology of mammalian retinal glial cells: role of lysophosphatidic acid. J Physiol (1998) 0.82
Inwardly-rectifying K(+) channels are major contributors to flow-induced vasodilation in resistance arteries. J Physiol (2016) 0.80
Assembly and suppression of endogenous Kv1.3 channels in human T cells. J Gen Physiol (1996) 0.80
Use of Kv1.3 blockers for inflammatory skin conditions. Curr Med Chem (2010) 0.80
Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life. J Biol Chem (2014) 0.79
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Transm (Vienna) (2014) 0.79
Ion channel clustering enhances weak electric field detection by neutrophils: apparent roles of SKF96365-sensitive cation channels and myeloperoxidase trafficking in cellular responses. Eur Biophys J (2005) 0.78
Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production. J Clin Invest (1994) 0.77
P2 receptor modulation of voltage-gated potassium currents in Brown adipocytes. J Gen Physiol (1999) 0.76
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840. Expert Opin Ther Pat (2010) 0.76
Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts. Biomed Res Int (2015) 0.75
T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers. PLoS One (2017) 0.75
Structure-activity relationship exploration of Kv1.3 blockers based on diphenoxylate. Bioorg Med Chem Lett (2012) 0.75
Regulation of Proliferation by a Mitochondrial Potassium Channel in Pancreatic Ductal Adenocarcinoma Cells. Front Oncol (2017) 0.75
Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain. EMBO J (1989) 5.66
Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (1985) 5.06
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature (1984) 4.70
Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem (1990) 3.98
K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion. Nature (1984) 2.89
Stimulation of the T3-T cell receptor complex induces a membrane-potential-sensitive calcium influx. Cell (1985) 2.69
Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med (1984) 2.54
Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron (1990) 2.38
Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci U S A (1988) 1.92
Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc Natl Acad Sci U S A (1990) 1.85
Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. Eur J Immunol (1990) 1.75
Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes. J Gen Physiol (1989) 1.69
Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci U S A (1992) 1.65
Calcium and T lymphocyte activation. Cell (1989) 1.61
Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes. J Clin Invest (1986) 1.53
Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1989) 1.44
A family of three mouse potassium channel genes with intronless coding regions. Science (1990) 1.43
Characterization and functional expression of a rat genomic DNA clone encoding a lymphocyte potassium channel. J Immunol (1990) 1.41
Role of membrane potential in the regulation of lectin-induced calcium uptake. J Cell Physiol (1984) 1.34
Triggering of T-lymphocytes via either T3-Ti or T11 surface structures opens a voltage-insensitive plasma membrane calcium-permeable channel: requirement for interleukin-2 gene function. J Biol Chem (1989) 1.28
Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes. Evidence for association with the voltage-gated K+ channel. J Biol Chem (1991) 1.12
FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. Cell Immunol (1991) 1.12
Heterogeneity of lymphocyte calcium metabolism is caused by T cell-specific calcium-sensitive potassium channel and sensitivity of the calcium ATPase pump to membrane potential. J Exp Med (1988) 1.00
Membrane depolarization selectively inhibits receptor-operated calcium channels in human T (Jurkat) lymphoblasts. Biochim Biophys Acta (1990) 0.95
Nitrendipine-induced inhibition of calcium influx in a human T-cell clone: role of cell depolarization. Cell Calcium (1991) 0.94
The inhibitory effects of K+ channel-blocking agents on T lymphocyte proliferation and lymphokine production are "nonspecific". J Immunol (1987) 0.87
Charybdotoxin-sensitive, Ca(2+)-dependent membrane potential changes are not involved in human T or B cell activation and proliferation. J Immunol (1991) 0.86
Blocking of human T lymphocyte activation by channel antagonists. Cell Biochem Funct (1989) 0.83
A third-generation lentivirus vector with a conditional packaging system. J Virol (1998) 16.07
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
Resolution of the early placental mammal radiation using Bayesian phylogenetics. Science (2001) 8.68
Protein methylation in behavioural control mechanisms and in signal transduction. Nature (1979) 6.87
Sensory transduction in Escherichia coli: two complementary pathways of information processing that involve methylated proteins. Proc Natl Acad Sci U S A (1977) 6.63
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science (2003) 6.35
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature (1989) 5.53
Parallel adaptive radiations in two major clades of placental mammals. Nature (2001) 4.65
Regulated targeting of BAX to mitochondria. J Cell Biol (1998) 4.17
Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem (1990) 3.98
Sensory transduction in Escherichia coli: role of a protein methylation reaction in sensory adaptation. Proc Natl Acad Sci U S A (1977) 3.93
Assessing B cell diversification by antigen receptor and precursor cell analysis. Ann Immunol (Paris) (1976) 3.88
The peritoneal exudate lymphocyte. I. Differences in antigen responsiveness between peritoneal exudate and lymph node lymphocytes from immunized guinea pigs. J Exp Med (1971) 3.81
A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc Natl Acad Sci U S A (1996) 3.43
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum (2001) 3.37
Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol (1990) 3.29
Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release. Neuron (1993) 3.07
Determinant selection is a macrophage dependent immune response gene function. Nature (1977) 2.85
p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol (1997) 2.84
Failure of sensory adaptation in bacterial mutants that are defective in a protein methylation reaction. Cell (1978) 2.81
A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol Sci (1999) 2.71
Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med (1996) 2.64
Primary sequence and immunological characterization of beta-subunit of high conductance Ca(2+)-activated K+ channel from smooth muscle. J Biol Chem (1994) 2.62
[Difficulties with immunofixation interpretation]. Ann Biol Clin (Paris) (2004) 2.56
Molecular evidence for multiple origins of Insectivora and for a new order of endemic African insectivore mammals. Proc Natl Acad Sci U S A (1998) 2.44
High-conductance calcium-activated potassium channels; structure, pharmacology, and function. J Bioenerg Biomembr (1996) 2.31
Overnight orthokeratology. Optom Vis Sci (2000) 2.27
Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med (1999) 2.25
Depletion of antibody-forming cells and their precursors from complex lymphoid cell populations. J Immunol (1972) 2.24
Characterization of and modulation by a beta-subunit of a human maxi KCa channel cloned from myometrium. Receptors Channels (1995) 2.24
Role of methionine in bacterial chemotaxis: requirement for tumbling and involvement in information processing. Proc Natl Acad Sci U S A (1975) 2.16
Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes (1994) 2.16
The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J Immunol (1990) 2.11
Pleiotropic aspartate taxis and serine taxis mutants of Escherichia coli. J Gen Microbiol (1979) 2.08
Attractants and repellents control demethylation of methylated chemotaxis proteins in Escherichia coli. Proc Natl Acad Sci U S A (1979) 1.99
Production of antibodies of identical idiotype but diverse immunoglobulin classes by cells derived from a single stimulated B cell. Proc Natl Acad Sci U S A (1975) 1.96
Molecular evidence regarding the origin of echolocation and flight in bats. Nature (2000) 1.94
Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J Biol Chem (1993) 1.94
Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol (1992) 1.93
Sensory transduction in Escherichia coli: a requirement for methionine in sensory adaptation. Proc Natl Acad Sci U S A (1977) 1.92
Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem (1999) 1.92
Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci U S A (1988) 1.92
Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. J Biol Chem (1994) 1.89
Breast-cancer diagnosis with nipple fluid bFGF. Lancet (2000) 1.86
Mode of action of iberiotoxin, a potent blocker of the large conductance Ca(2+)-activated K+ channel. Biophys J (1992) 1.86
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther (1989) 1.82
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry (1991) 1.77
Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. Arthritis Care Res (Hoboken) (2013) 1.76
E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol (1998) 1.75
Heterogeneity of the BALB/c antiphosphorylcholine antibody response at the precursor cell level. J Exp Med (1975) 1.75
Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc Natl Acad Sci U S A (1994) 1.73
Attraction by repellents: an error in sensory information processing by bacterial mutants. Science (1978) 1.73
Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem (1998) 1.73
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR. Eur J Cancer (1999) 1.72
Capacity of the clinical picture to characterize low back pain relieved by facet joint anesthesia. Proposed criteria to identify patients with painful facet joints. Spine (Phila Pa 1976) (1998) 1.71
Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci (1996) 1.71
Sensory transduction in Escherichia coli: regulation of the demethylation rate by the CheA protein. Proc Natl Acad Sci U S A (1984) 1.70
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Dynamics of subjective contour formation in the early visual cortex. Proc Natl Acad Sci U S A (2001) 1.69
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 1.66
Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci U S A (1992) 1.65
Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis (1996) 1.64
Enhancement of neutrophils function as a result of prior exposure to chemotactic factor. J Clin Invest (1980) 1.64
Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol (1988) 1.62
Active transport in membrane vesicles from Escherichia coli: the electrochemical proton gradient alters the distribution of the lac carrier between two different kinetic states. Biochemistry (1980) 1.60
Human breast carcinoma desmoplasia is PDGF initiated. Oncogene (2000) 1.59
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci U S A (2001) 1.58
Autocastration as a presenting sign of incipient schizophrenia. Psychiatr Serv (2001) 1.57
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA (2001) 1.57
High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage (1993) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB/C mice. J Immunol (1975) 1.55
Phylogenetic relationships of living and recently extinct bandicoots based on nuclear and mitochondrial DNA sequences. Mol Phylogenet Evol (2011) 1.55
An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry (1993) 1.55
Purification and reconstitution of the high-conductance, calcium-activated potassium channel from tracheal smooth muscle. J Biol Chem (1994) 1.54
Oxidative regulation of large conductance calcium-activated potassium channels. J Gen Physiol (2001) 1.54
Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1. J Exp Med (1993) 1.52
Coexisting thyroid and parathyroid disease--are they related? Surgery (1983) 1.51
Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity. J Biol Chem (1991) 1.51
FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins. Proc Natl Acad Sci U S A (1991) 1.49
Differential expression of an equivalent clonotype among BALB/c and C57BL/6 mice. J Exp Med (1978) 1.49
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J Exp Med (1992) 1.46
The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest (1999) 1.45
Purified reconstituted lac carrier protein from Escherichia coli is fully functional. Proc Natl Acad Sci U S A (1984) 1.40
Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry (1992) 1.40
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity (2000) 1.40
Clinical usefulness of estimation of serum fructosamine concentration as screening test for gestational diabetes. Am J Obstet Gynecol (1989) 1.39
Development of C5a receptor antagonists. Differential loss of functional responses. J Immunol (1994) 1.39